Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma

por Yancey, Steven W., Ortega, Hector G., Keene, Oliver N., Bradford, Eric S.
Publicado 2019

Rectovaginal Fistula From Untreated Ulcerative Colitis in Pregnancy: A Case Report and Review of the Literature

por Altshuler, Paulina C, Bradford, Eric, van Swaay, Annette, Rabice, Sarah, Gaffney, Rachel
Publicado 2023

The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

por Shabbir, Shaila, Pouliquen, Isabelle J., Bentley, Jane H., Bradford, Eric S., C. Kaisermann, Morrys, Albayaty, Muna
Publicado 2019

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

por Prazma, Charlene M., Bel, Elisabeth H., Price, Robert G., Bradford, Eric S., Albers, Frank C., Yancey, Steven W.
Publicado 2019

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA

por Albers, Frank C., Papi, Alberto, Taillé, Camille, Bratton, Daniel J., Bradford, Eric S., Yancey, Steven W., Kwon, Namhee
Publicado 2019

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

por Gupta, Atul, Pouliquen, Isabelle, Austin, Daren, Price, Robert G., Kempsford, Rodger, Steinfeld, Jonathan, Bradford, Eric S., Yancey, Steven W.
Publicado 2019

Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials

por Lemiere, Catherine, Taillé, Camille, Lee, Jason Kihyuk, Smith, Steven G., Mallett, Stephen, Albers, Frank C., Bradford, Eric S., Yancey, Steven W., Liu, Mark C.
Publicado 2021

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions

por Gibson, Peter G., Prazma, Charlene M., Chupp, Geoffrey L., Bradford, Eric S., Forshag, Mark, Mallett, Stephen A., Yancey, Steve W., Smith, Steven G., Bel, Elisabeth H.
Publicado 2021

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO

por Pavord, Ian D, Chapman, Kenneth R, Bafadhel, Mona, Sciurba, Frank C, Bradford, Eric S, Schweiker Harris, Stephanie, Mayer, Bhabita, Rubin, David B, Yancey, Steven W, Paggiaro, Pierluigi
Publicado 2021

Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)

por Moore, Wendy C., Kornmann, Oliver, Humbert, Marc, Poirier, Claude, Bel, Elisabeth H., Kaneko, Norihiro, Smith, Steven G., Martin, Neil, Gilson, Martyn J., Price, Robert G., Bradford, Eric S., Liu, Mark C.
Publicado 2022

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial

por Roufosse, Florence, Kahn, Jean-Emmanuel, Rothenberg, Marc E., Wardlaw, Andrew J., Klion, Amy D., Kirby, Suyong Yun, Gilson, Martyn J., Bentley, Jane H., Bradford, Eric S., Yancey, Steven W., Steinfeld, Jonathan, Gleich, Gerald J.
Publicado 2020

The value of blood cytokines and chemokines in assessing COPD

por Bradford, Eric, Jacobson, Sean, Varasteh, Jason, Comellas, Alejandro P., Woodruff, Prescott, O’Neal, Wanda, DeMeo, Dawn L., Li, Xingnan, Kim, Victor, Cho, Michael, Castaldi, Peter J., Hersh, Craig, Silverman, Edwin K., Crapo, James D., Kechris, Katerina, Bowler, Russell P.
Publicado 2017

Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study

por Engelkes, Marjolein, Baan, Esme J., de Ridder, Maria A. J., Svensson, Elisabeth, Prieto‐Alhambra, Daniel, Lapi, Francesco, Giaquinto, Carlo, Picelli, Gino, Boudiaf, Nada, Albers, Frank, Evitt, Lee A., Cockle, Sarah, Bradford, Eric, Van Dyke, Melissa K., Suruki, Robert, Rijnbeek, Peter, Sturkenboom, Miriam C. J. M., Janssens, Hettie M., Verhamme, Katia M. C.
Publicado 2020